Search

INDIANAPOLIS: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) today announced the opening of the Lilly Seaport Innovation Center (LSC), a research [...]

NEW YORK & CAMBRIDGE, England: EMPYREAN NEUROSCIENCE, INC. has issued the following news release: Empyrean Neuroscience, Inc., a genetic engineering company dedicated to developing neuroactive compounds to treat neuropsychiatric and [...]

BOULDER, Colo.: Enveda Biosciences announced the appointment of Mark Deeg, M.D., Ph.D., as the company's Chief Medical Officer. Dr. Deeg is a medical and pharmaceutical leader with broad experience developing [...]

FRIDAY, Feb. 11, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the omicron variant. [...]

Byline: Dennis Thompson FRIDAY, Feb. 11, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against [...]

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series - Biopharma's Next Decade: Views [...]

INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series -- Biopharma's Next Decade: Views from the Top on Global [...]

Respected industry leader will spearhead company's small molecule drug discovery portfolio SOUTH RIDING, Va., April 29, 2021 /PRNewswire-PRWeb/ -- Slone Partners, a nationwide executive search firm for life science, biotechnology, [...]

WASHINGTON, April 19, 2021 /PRNewswire/ -- The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation (NYSE: NVTA) to [...]

Byline: Samantha Long However, for patients with a high risk of disease progression, hospitalisation and accident and emergency (A&E) visits occurred in 3% of bamlanivimab-treated patients compared to 10% of [...]

INDIANAPOLIS: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE:LLY) will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area [...]

INDIANAPOLIS, March 22, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area health care workers beginning Monday, [...]

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE:LLY) announced today its scientists are partnering with the Indiana State Department of Health (ISDH), [...]

INDIANAPOLIS, March 18, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) announced today its scientists are partnering with the Indiana State Department of Health (ISDH), with support from the Food [...]

Dublin: Eli Lilly has issued the following press release: Eli Lilly and Company (NYSE: LLY) today announced new leadership and strategic direction in oncology R&D, combining the Lilly Research Laboratories [...]

New organization to combine speed and agility of Loxo with scale and capabilities of Lilly INDIANAPOLIS, Dec. 5, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new [...]

Indiana: Indiana Biosciences Research Institute has issued the following press release: The Indiana Biosciences Research Institute (IBRI) today announced new investigators for the IBRI Diabetes Center (IDC). At its first [...]

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, [...]

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company ( NYSE : LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, [...]

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, [...]

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, [...]

Dublin: Eli Lilly has issued the following press release: Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, 2018. Jan [...]

INDIANAPOLIS: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, [...]

INDIANAPOLIS, Jan. 26, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, 2018. Jan Lundberg, Ph.D., executive [...]

Indianapolis: Following is the Profile of Jan M. Lundberg Executive Vice President, Science and Technology, and President, Research Laboratories of Eli Lilly and Company: Jan Lundberg is executive vice president [...]

Indianapolis: Following is the Profile of Stephen F. Fry Senior Vice President, Human Resources and Diversity of Eli Lilly and Company: Steve Fry is senior vice president, human resources and [...]

INDIANAPOLIS: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) will participate in the Credit Suisse 26th Annual Healthcare Conference on Tuesday, November [...]

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company ( NYSE : LLY) will participate in the Credit Suisse 26th Annual Healthcare Conference on [...]

Basingstoke, UK: Eli Lilly has issued the following press release: Eli Lilly and Company (NYSE: LLY) will participate in the Credit Suisse 26th Annual Healthcare Conference on Tuesday, November 7, [...]

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) will participate in the Credit Suisse 26th Annual Healthcare Conference on Tuesday, November [...]

Indiana: Eli Lilly has issued the following press release: Eli Lilly and Company (NYSE: LLY) will participate in the Credit Suisse 26th Annual Healthcare Conference on Tuesday, November 7, 2017. [...]

INDIANAPOLIS: Eli Lilly and Company has issued the following news release: Eli Lilly and Company (NYSE: LLY) will participate in the Credit Suisse 26th Annual Healthcare Conference on Tuesday, November [...]

Burlington: Following is the Profile of Dr. Clayman of Flexion Therapeutics, Inc: Dr. Clayman is a co-founder of Flexion Therapeutics and has served as our President, Chief Executive Officer, and [...]

Burlington: Following is the Profile of Dr. Bodick of Flexion Therapeutics, Inc: Dr. Bodick is a co-founder and has served as our Chief Medical Officer since our inception in 2007. [...]

Uxbridge: Follwing is the Profile of Steven M. Paul Board of Director of Alnylam Pharmaceuticals: Chief Executive Officer, President, and board member of Voyager Therapeutics, Inc.; Venture Partner at Third [...]

London: Follwing is the Profile of Atul Pande board of Autifony Therapeutics: Atul Pande, M.D., is President of Verity BioConsulting, an independent drug development consulting firm. Previously he was Senior [...]

Montreal, QC: Following is the Profile of Alice Ke Consultant and Scientific Advisor of Certara: Alice Ke obtained her PhD in pharmaceutics from the University of Washington, Seattle, where her [...]

Verona, Italy: Following is the Profile of Atul Pande Director of Autifony Therapeutics: Atul Pande, M.D., is President of Verity BioConsulting, an independent drug development consulting firm. Previously he was [...]

Ecublens: Follwing is the Profile of Mike Clayman CEO of Anokion: Dr. Clayman is a co-founder of Flexion Therapeutics and has served as President, Chief Executive Officer, and as a [...]

Boston : Following is the Profile of Atul Pande CMO, of Tal Medical: Atul is an industry veteran, with more than 25 years of experience in psychiatry and neurosciences. Most [...]

Boston : Following is the Profile of Steve Paul, MD of Tal Medical: Dr. Paul is a world renowned psychiatrist, neuroscientist and drug developer. Steve is the former president of [...]

South SF, CA: Following is the Profile of Homer L. Pearce, Ph.D. Director of Sunesis Pharmaceuticals: Dr. Pearce has served as a member of our board of directors since June [...]

Santa Monica, CA: Following is the Profile of Phil Skolnick, PhD, DSc (hon.) Chief Scientific Officer of OPIANT PHARMACEUTICALS, INC: Phil Skolnick has more than 45 years of pharmaceutical experience, [...]

Suzhou: Following is the Profile of Prof. Lian Yu - University of Wisconsin Solid-state chemistry of Crystal Pharmatech: Leading researcher on solid-state chemistry Research areas focused on polymorphism, crystallization of [...]

Baltimore, MD : Following is the Profile of Richard Mohs, PhD Vice President of Clinical Development of AgeneBio, Inc: Richard Mohs, PhD, has served as our Vice President of Clinical [...]

Brooklyn Park, MN: Following is the Profile of Jim Klancke Senior Director of Analytical Development of CIMA LABS INC: Jim Klancke is the Senior Director of Analytical Development at CIMA. [...]